Thymos Health · Health Systems

Expand specialist capacity.
Lower the cost of autoimmune care.

Thymos manages the high-frequency, longitudinal work between specialist visits—helping health systems serve more patients without adding specialist headcount or sending appropriate care outside the network.

See Your System's Opportunity How the Model Works
Physician-led autoimmune care  ·  5,000+ autoimmune patients treated  ·  Virtual nationwide model  ·  Appropriate escalation back to your specialists  ·
Physician-led autoimmune care  ·  5,000+ autoimmune patients treated  ·  Virtual nationwide model  ·  Appropriate escalation back to your specialists  ·
The Bottleneck

Autoimmune care is administratively heavy — and reimbursed like it isn't.

A typical autoimmune patient doesn't move through your system in a straight line. They move through this:

Specialist appointment
→
Labs
→
Another appointment
→
Portal triage
→
Another specialist
→
Biologic PA
→
Follow-up

Every step in that chain carries real administrative cost — prior auths, portal triage, care coordination — that your E&M reimbursement was never priced to cover.

Net contribution  =  reimbursement  −  fully loaded cost of delivering the visit
Autoimmune care is exactly where this math gets uncomfortable: the administrative intensity is disproportionate to the E&M reimbursement attached to it. Meanwhile, your appointment backlog keeps growing — and the complex new patients who actually need your specialists are the ones waiting months to get in.
The Thymos Solution

Why health systems partner with Thymos

Thymos quarterbacks the daily work of autoimmune management and continuous coordination with your specialists — lowering total cost of care while optimizing your capacity.

◎
Longitudinal, coordinated care
Increased care efficiency between visits allows your specialists to see more patients.
↓
Lowers total cost of care, per patient, per year
Fewer low-value repeat visits, duplicative tests, avoidable ED visits and hospitalizations.
▲
Frees scarce specialist capacity
Converts low-complexity follow-ups into room for the higher-acuity new patients currently waiting months for access to scarce specialist visits.
⌂
Keeps high-value care inside your system
Appropriate escalation back to your specialists and facilities when it's actually needed — no network leakage.
The Capacity Model

Unlock the capacity already inside your population.

Every specialist hour spent on a routine follow-up is an hour a higher-acuity patient waited to get. Here's what happens when Thymos takes on that work instead.

Illustrative model

This model currently reflects {{ patientsEcho }} autoimmune patients — adjust any field below to match your own population, reimbursement rates, and specialist capacity.

Physician reviewing patient data on a tablet
Today
Autoimmune patients
↓
Routine specialty encounters / year1
{{ encountersFmt }}
at visits/patient/yr
↓
Physician hours consumed2
{{ hoursFmt }}
↓
Reimbursement revenue3
${{ deliveryCostFmt }}
at $ / encounter
With Thymos
Longitudinal management handled by Thymos
%
↓
Specialist appointment slots released
{{ slotsFmt }}
↓
Additional new / high-acuity patients accommodated2
{{ newPatientsFmt }}
↓
Incremental reimbursement revenue4
+${{ contributionFmt }}
This is net-new revenue and contribution margin — added on top of the reimbursement your specialists already collect today, using capacity they already have.
Fixed model assumptions
30 min average physician time per routine specialty follow-up encounter2
1.5 released follow-ups ≈ 1 new/high-acuity slot — based on a 30-min established visit vs. a 45-min new/high-acuity evaluation2
$240 estimated incremental reimbursement revenue per additional new / high-acuity encounter4
Sources ▼
1. Clinical Visit Frequencies in Rheumatology: A Systematic Literature Review, PubMed, 2023 — reported annual specialty visit frequencies ranging ~2.7–5.25 depending on population and region; Thymos uses a blended cross-specialty estimate of 4.5 within that range.
2. American Medical Association CPT E/M time definitions — established patient visits (99214: 30–39 min) vs. new patient visits (99204: 45–59 min).
3. CMS Physician Fee Schedule, national average non-facility rate for CPT 99214 ($135.61, effective Jan. 1, 2026). Commercial payers typically reimburse 120–250% of Medicare; Thymos uses the midpoint (~185%) to approximate average commercial-weighted reimbursement revenue per routine follow-up encounter (~$260/encounter default).
4. CMS Physician Fee Schedule, national average non-facility rate for CPT 99204 (~$120, effective Jan. 1, 2026), grossed up to ~200% to reflect typical commercial payer reimbursement for new / high-acuity patients (120–250% of Medicare).

Illustrative model — we'll calculate this using your health system's utilization and reimbursement data.

Calculate Your Capacity Opportunity
The Economics

Less expensive infrastructure. Same population.

Thymos manages routine longitudinal management to the appropriate level of care:

Specialist appointment
→
Labs
→
Another appointment
→
Portal triage
→
Another specialist
→
Biologic PA
→
Follow-up
with
Centralized longitudinal management + appropriate specialist escalation

Same clinical standard and expertise. The health system can care for it with materially less expensive clinical infrastructure.

Four Value Propositions, Simultaneously

Capacity. Cost. Results. Retention.

Thymos expands autoimmune capacity without requiring the health system to hire more specialists.

Physician on a telehealth videoconference consult
01 · Capacity
More patients per specialist
Increase access and open more appointments for complex new patients.
02 · Cost
Lower cost to manage
Shift routine longitudinal work to a lower-cost autoimmune care infrastructure.
03 · Results
Better patient and provider experiences
Patient support continuity drives better outcomes while specialists focus on what matters most and reduce monitoring and coordination.
04 · Retention
Downstream revenue retention, no leakage
Fewer unnecessary appointments enables patients to receive appropriate specialist, procedural, infusion and facility care.
We move autoimmune care to the lowest-cost appropriate level, free scarce specialist capacity, and keep high-value care inside your system.
Departments We Support

Thymos supports every specialty that touches autoimmune disease

Thymos moves autoimmune care to the lowest-cost appropriate level, frees scarce specialist capacity, and keeps high-value care inside your system.

Rheumatology
✓Longitudinal management of RA, lupus, psoriatic arthritis, and ankylosing spondylitis between visits
✓Continuous DMARD and biologic monitoring, with lab and symptom tracking
✓Taper readiness evaluation and clinical exit support
✓Escalation back to rheumatology for flares or treatment failure
Gastroenterology
✓Maintenance-phase management of Crohn's disease and ulcerative colitis
✓Biologic monitoring and step-therapy documentation support
✓Symptom and lab surveillance between colonoscopies and infusions
✓Escalation for flares, loss of response, or surgical evaluation
Dermatology
✓Ongoing management of psoriasis, alopecia areata, and biologic-treated skin disease
✓Biologic and JAK inhibitor monitoring between visits
✓Screening for psoriatic arthritis and other comorbid autoimmune disease
✓Escalation for non-response or new joint symptoms
Neurology
✓Longitudinal follow-up for multiple sclerosis, myasthenia gravis, and Guillain-Barré recovery
✓Continuous symptom and functional-status monitoring between infusions
✓Medication adherence and side-effect tracking
✓Escalation for relapse, progression, or crisis risk
Endocrinology
✓Management of Hashimoto's thyroiditis and other autoimmune endocrine disease
✓Lab-driven dose titration support between visits
✓Root-cause investigation for patients still symptomatic on standard therapy
✓Escalation for comorbidities or treatment-resistant cases
Primary Care
✓Early symptom triage for suspected autoimmune disease
✓Referral coordination to the right specialist, the first time
✓Medication reconciliation across specialists
✓Ongoing support for patients between specialty visits
Easy to Implement

Start focused. Prove the impact. Scale.

Thymos extends your existing specialty infrastructure without requiring additional specialist headcount or an enterprise-wide transformation.

1
Identify the opportunity
Start with the specialty, patient population, or access bottleneck where additional capacity can create the most value. Initial analysis can begin with de-identified data.
2
Fit into your existing workflows
Together, we define referral criteria, clinical responsibilities, communication workflows, and clear escalation pathways back to your specialists.
3
Launch a focused pilot
Begin with one service line, geography, or patient cohort. Thymos provides the physician-led longitudinal care infrastructure without requiring your system to build a new program from scratch.
4
Measure, then scale
Track the outcomes that matter to your system, including specialist capacity, access, utilization, cost, patient experience, and appropriate escalation. Expand across specialties as the model demonstrates value.
No enterprise-wide transformation on day one. Start with one population, prove the value, and scale from there.

Request a Health System Analysis

We lower the cost of managing autoimmune patients by augmenting your team, without losing patients to outside networks. Let's discuss what Thymos could unlock for your system.

De-identified population analysis · No PHI required to start · Physician-led clinical model
✓

Thank you.

A member of our partnerships team will be in touch shortly.
Thymos Health needs your information to contact you about partnering for our services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.
Something went wrong submitting the form. Please try again in a moment.
Thymos Health
Founded by Dr. Payal Bhandari, MD · Integrative functional medicine
5,000+ autoimmune patients treated · Virtual care · Clinician-led taper programs